Lentiviral interferon: A novel method for gene therapy in bladder cancer

Interferon alpha (IFNα) gene therapy is emerging as a new treatment option for patients with non-muscle invasive bladder cancer (NMIBC). Adenoviral vectors expressing IFNα have shown clinical efficacy treating bacillus Calmette-Guerin (BCG)-unresponsive bladder cancer (BLCA). However, transient tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokkapati, Sharada, Narayan, Vikram M., Manyam, Ganiraju C., Lim, Amy H., Duplisea, Jonathan J., Kokorovic, Andrea, Miest, Tanner S., Mitra, Anirban P., Plote, Devin, Anand, Selvalakshmi Selvaraj, Metcalfe, Michael J., Dunner, Kenneth, Johnson, Burles A., Czerniak, Bogdan A., Nieminen, Tiina, Heikura, Tommi, Yla-Herttuala, Seppo, Parker, Nigel R., Schluns, Kimberley S., McConkey, David J., Dinney, Colin P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251210/
https://www.ncbi.nlm.nih.gov/pubmed/35847448
http://dx.doi.org/10.1016/j.omto.2022.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251210/
https://www.ncbi.nlm.nih.gov/pubmed/35847448
http://dx.doi.org/10.1016/j.omto.2022.06.005

Ejemplares similares